vTv Therapeutics Inc. (NASDAQ: VTVT)
$14.0500
+0.0400 ( -5.67% ) 3.4K
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Market Data
Open
$14.0500
Previous close
$14.0100
Volume
3.4K
Market cap
$36.60M
Day range
$14.2750 - $14.8950
52 week range
$7.3800 - $30.9900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 06, 2024 |
| 4 | Insider transactions | 1 | Dec 06, 2024 |
| 4 | Insider transactions | 1 | Nov 19, 2024 |
| 8-k | 8K-related | 15 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 64 | Nov 12, 2024 |
| 8-k | 8K-related | 13 | Oct 25, 2024 |
| 10-q | Quarterly Reports | 64 | Aug 08, 2024 |
| 8-k | 8K-related | 15 | Aug 08, 2024 |
| 8-k | 8K-related | 14 | Jul 26, 2024 |
| 8-k | 8K-related | 13 | Jul 02, 2024 |